Security
GLOBUS MEDICAL INC · GMED
GMEDNYSECommon stockCurrentCIK 1237831Updated Nov 2, 2026
GMED price & chart
Loading TradingView…
NYSE:GMED on TradingView ↗About the company
Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
In the news
Globus Medical Reports Second Quarter 2026 Results ↗
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED) ↗
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results News provided by Nevro Corp. Mar 04, 2025, 16:15 ET Share this article Share to X Share this article Share to X REDWOOD CITY, Calif. , March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO ), a global medical device company that is de ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 5,095,640,000Source | 5,086,044,000Source | 5,488,258,000Source | 4,961,089,000Source | 4,993,793,000Source | 5,439,555,000Source | 4,711,148,000Source | 4,943,612,000Source | 5,302,761,000Source | 5,251,750,000Source | 5,086,083,000Source | 2,076,126,000Source |
| Property, Plant and Equipment, NetUSD | 577,791,000Source | 567,822,000Source | 533,528,000Source | 587,505,000Source | 571,776,000Source | 557,139,000Source | 556,496,000Source | 578,887,000Source | 564,452,000Source | 561,909,000Source | 586,932,000Source | 243,729,000Source |
| GoodwillUSD | 1,434,291,000Source | 1,431,666,000Source | 1,438,216,000Source | 1,434,983,000Source | 1,454,117,000Source | 1,438,733,000Source | 1,432,964,000Source | 1,451,106,000Source | 1,435,033,000Source | 1,432,387,000Source | 1,434,540,000Source | 197,471,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 773,902,000Source | 842,778,000Source | 692,624,000Source | 796,372,000Source | 866,565,000Source | 720,845,000Source | 771,688,000Source | 888,208,000Source | 745,064,000Source | 795,117,000Source | 924,603,000Source | 63,574,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 507,745,000Source | — | — | 560,950,000Source | — | — | 526,156,000Source | — | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 619,116,000Source | 588,047,000Source | 692,176,000Source | 611,565,000Source | 611,784,000Source | 686,433,000Source | 535,090,000Source | 534,333,000Source | 678,938,000Source | 557,697,000Source | 503,235,000Source | 213,247,000Source |
| Inventory, NetUSD | 771,538,000Source | 717,703,000Source | 810,897,000Source | 772,131,000Source | 770,463,000Source | 772,602,000Source | 663,603,000Source | 816,196,000Source | 759,277,000Source | 659,233,000Source | 848,135,000Source | 298,981,000Source |
| Assets, CurrentUSD | 1,924,361,000Source | 2,056,529,000Source | 2,215,512,000Source | 1,729,902,000Source | 1,923,891,000Source | 2,198,120,000Source | 1,710,114,000Source | 1,828,574,000Source | 2,125,611,000Source | 2,177,260,000Source | 1,915,374,000Source | 983,344,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 74,177,000Source | 50,924,000Source | 70,195,000Source | 68,202,000Source | 46,213,000Source | 60,228,000Source | 47,131,000Source | 43,209,000Source | 65,426,000Source | 49,640,000Source | 44,580,000Source | 20,997,000Source |
| Operating Lease, Right-of-Use AssetUSD | 59,411,000Source | 52,824,000Source | 59,155,000Source | 61,587,000Source | 53,881,000Source | 61,507,000Source | 48,367,000Source | 56,347,000Source | 63,786,000Source | 49,647,000Source | 59,931,000Source | — |
| Other Assets, NoncurrentUSD | 76,838,000Source | 76,643,000Source | 79,238,000Source | 74,843,000Source | 77,569,000Source | 78,964,000Source | 74,856,000Source | 78,216,000Source | 78,781,000Source | 75,096,000Source | 78,590,000Source | 43,311,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 696,815,000Source | 1,016,647,000Source | 719,655,000Source | 665,406,000Source | 1,017,428,000Source | 707,243,000Source | 623,080,000Source | 1,021,251,000Source | 729,511,000Source | 1,074,417,000Source | 1,088,124,000Source | 229,753,000Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 3,095,279,000Source | 2,949,917,000Source | 3,230,186,000Source | 3,071,652,000Source | 2,913,609,000Source | 3,205,514,000Source | 3,053,927,000Source | 2,886,436,000Source | 3,169,812,000Source | 3,031,244,000Source | 2,870,749,000Source | 630,952,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,292,485,000Source | 1,126,308,000Source | 1,527,087,000Source | 1,213,657,000Source | 1,074,472,000Source | 1,512,259,000Source | 1,036,173,000Source | 1,046,835,000Source | 1,387,957,000Source | 1,152,813,000Source | 1,137,266,000Source | 1,239,951,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 10,927,000Source | -6,963,000Source | 11,196,000Source | 10,239,000Source | -11,851,000Source | 14,404,000Source | -2,167,000Source | -11,045,000Source | 15,346,000Source | -6,861,000Source | -10,192,000Source | -24,630,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,398,825,000Source | 4,069,397,000Source | 4,768,603,000Source | 4,295,683,000Source | 3,976,365,000Source | 4,732,312,000Source | 4,088,068,000Source | 3,922,361,000Source | 4,573,250,000Source | 4,177,333,000Source | 3,997,959,000Source | 1,846,373,000Source |
| Liabilities and EquityUSD | 5,095,640,000Source | 5,086,044,000Source | 5,488,258,000Source | 4,961,089,000Source | 4,993,793,000Source | 5,439,555,000Source | 4,711,148,000Source | 4,943,612,000Source | 5,302,761,000Source | 5,251,750,000Source | 5,086,083,000Source | 2,076,126,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 465,958,000Source | 818,065,000Source | 479,347,000Source | 424,664,000Source | 794,146,000Source | 482,463,000Source | 384,701,000Source | 786,324,000Source | 498,499,000Source | 855,913,000Source | 392,347,000Source | 159,204,000Source |
| Operating Lease, Liability, CurrentUSD | 14,355,000Source | 11,040,000Source | 14,385,000Source | 13,179,000Source | 11,118,000Source | 15,121,000Source | 10,622,000Source | 11,749,000Source | 14,738,000Source | 10,249,000Source | 11,967,000Source | — |
| Accounts Payable, CurrentUSD | 87,227,000Source | 57,537,000Source | 106,941,000Source | 87,099,000Source | 67,163,000Source | 103,658,000Source | 73,144,000Source | 50,487,000Source | 98,852,000Source | 75,118,000Source | 56,671,000Source | 36,101,000Source |
| Operating Lease, Liability, NoncurrentUSD | 104,988,000Source | 86,376,000Source | 96,807,000Source | 107,925,000Source | 87,702,000Source | 100,102,000Source | 81,691,000Source | 89,809,000Source | 103,918,000Source | 83,588,000Source | 91,037,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | 22,538,000Source | 7,475,000Source | — | 24,402,000Source | 27,264,000Source | — | 46,605,000Source | 39,952,000Source | — | 23,889,000Source | 84,421,000Source | 1,779,000Source |
| Other Liabilities, NoncurrentUSD | 25,084,000Source | 22,983,000Source | 19,046,000Source | 22,062,000Source | 25,205,000Source | 20,576,000Source | 25,486,000Source | 23,505,000Source | 21,343,000Source | 21,531,000Source | 24,596,000Source | 13,820,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 325,924,000Source | 255,260,000Source | 300,728,000Source | 281,747,000Source | 215,885,000Source | 313,431,000Source | 237,566,000Source | 210,011,000Source | 333,586,000Source | 260,591,000Source | 240,460,000Source | 94,705,000Source |
| Deferred Revenue, CurrentUSD | 18,267,000Source | 20,802,000Source | — | 24,020,000Source | 19,845,000Source | — | 17,172,000Source | 17,077,000Source | — | 22,140,000Source | 18,369,000Source | 14,100,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 48,693,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 69,856,000Source | 65,653,000Source | 276,842,000Source | 254,024,000Source | 144,733,000Source | 68,252,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 12,617,000Source | 13,206,000Source | 49,779,000Source | 54,191,000Source | 52,742,000Source | 32,810,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 13,399,000Source | -22,603,000Source | 52,182,000Source | 78,062,000Source | 49,914,000Source | 50,843,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 16,651,000Source | 7,587,000Source | 17,598,000Source | 29,860,000Source | 70,328,000Source | 61,745,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 5,082,000Source | -899,000Source | 8,487,000Source | 17,663,000Source | -14,223,000Source | 14,418,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -134,037,000Source | -58,249,000Source | -22,330,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 202,364,000Source | 177,300,000Source | 753,447,000Source | 520,638,000Source | 243,499,000Source | 178,468,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 4,909,000Source | 5,000,000Source | 252,546,000Source | 17,635,000Source | 296,028,000Source | 31,435,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -182,674,000Source | 131,385,000Source | -355,014,000Source | -176,051,000Source | 302,968,000Source | -110,362,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 39,615,000Source | 36,103,000Source | 164,679,000Source | 115,429,000Source | 78,274,000Source | 74,047,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 3,440,000Source | 2,293,000Source | 2,909,000Source | 6,729,000Source | 10,617,000Source | — |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 190,451,000Source | 300,451,000Source | 85,787,000Source | 225,562,000Source | 144,493,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 18,197,000Source | -635,396,000Source | -679,160,000Source | -27,696,000Source | -231,821,000Source | -109,962,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 34,794,000Source | -323,172,000Source | -258,282,000Source | 317,146,000Source | 316,826,000Source | -42,603,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 371,769,000Source | 622,766,000Source | 507,745,000Source | 229,446,000Source | 560,950,000Source | 461,266,000Source | 526,156,000Source | 784,438,000Source | 467,292,000Source | 150,466,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 5,991,000Source | 7,199,000Source | 98,916,000Source | 158,508,000Source | 100,593,000Source | 77,823,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -3,093,000Source | 3,539,000Source | 22,445,000Source | 255,000Source | 2,180,000Source | -747,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 11,538,000Source | 12,211,000Source | 13,383,000Source | 13,617,000Source | 12,617,000Source | 13,206,000Source | 49,779,000Source | 54,191,000Source | 38,995,000Source | 32,810,000Source |
| Amortization of Intangible AssetsUSD | — | — | 29,843,000Source | 30,076,000Source | 29,560,000Source | 30,189,000Source | 29,526,000Source | 28,802,000Source | 118,194,000Source | 119,373,000Source | 51,032,000Source | 17,735,000Source |
| DepreciationUSD | — | — | 41,284,000Source | 36,873,000Source | 40,525,000Source | 40,442,000Source | 40,595,000Source | 37,272,000Source | 159,286,000Source | 134,651,000Source | 93,702,000Source | 50,517,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -161,000Source | 10,279,000Source | -860,000Source | 38,000Source | -2,113,000Source | 4,270,000Source | -3,006,000Source | -43,285,000Source | 14,259,000Source | -1,020,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | -3,000,000Source | -43,300,000Source | 14,100,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | -2,449,000Source | -2,613,000Source | -12,525,000Source | -5,552,000Source | -1,541,000Source | -299,000Source |
| GoodwillUSD | — | — | 1,434,291,000Source | 1,431,666,000Source | 1,438,216,000Source | 1,434,983,000Source | 1,438,733,000Source | 1,432,964,000Source | 1,435,033,000Source | 1,432,387,000Source | 1,434,540,000Source | 197,471,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | 0Source | — | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 25,028,000Source | 5,196,000Source | 38,248,000Source | -14,673,000Source | 32,772,000Source | 28,206,000Source | 67,200,000Source | 17,738,000Source | 42,520,000Source | 52,850,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | 4,960,000Source | 5,960,000Source | 22,119,000Source | 23,359,000Source | 10,959,000Source | 6,400,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 118,966,000Source | 51,836,000Source | 151,569,000Source | 202,846,000Source | 124,302,000Source | 75,462,000Source | 537,868,000Source | 102,984,000Source | 122,873,000Source | 190,169,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 118,966,000Source | 51,836,000Source | 151,569,000Source | 202,846,000Source | 124,301,000Source | 75,462,000Source | 537,868,000Source | 102,984,000Source | 122,873,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 6,631,000Source | 8,934,000Source | 7,385,000Source | 112,064,000Source | 6,686,000Source | 6,664,000Source | 125,252,000Source | -45,269,000Source | — | — |
| Operating ExpensesUSD | — | — | — | — | — | — | — | — | — | — | 887,160,000Source | 531,167,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 1,537,000Source | -570,000Source | 1,171,000Source | 772,000Source | 2,247,000Source | 713,000Source | 3,413,000Source | 2,205,000Source | 32,251,000Source | 15,068,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | 1,750,000Source | — | 113,504,000Source | 100,643,000Source | 419,534,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | — | 58,630,000Source | 63,880,000Source | 58,666,000Source | 240,190,000Source | 312,221,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 25,961,000Source | 11,223,000Source | 89,757,000Source | 110,439,000Source | 12,397,000Source | 41,716,000Source |
| Restructuring CostsUSD | — | — | 358,000Source | 5,191,000Source | 1,957,000Source | 13,547,000Source | 5,212,000Source | 0Source | 15,049,000Source | 23,773,000Source | — | — |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | — | 11,508,000Source | 12,303,000Source | 13,423,000Source | 40,583,000Source | 12,788,000Source | 13,324,000Source | 76,530,000Source | 54,286,000Source | 52,773,000Source | 33,467,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 769,048,000Source | 625,705,000Source | 789,612,000Source | 745,342,000Source | 759,854,000Source | 598,121,000Source | 2,938,931,000Source | 2,519,355,000Source | 1,568,476,000Source | 1,022,843,000Source |
| Cost of RevenueUSD | — | — | 252,533,000Source | 270,515,000Source | 241,439,000Source | 248,765,000Source | 234,066,000Source | 195,397,000Source | 957,802,000Source | 1,035,479,000Source | 548,174,000Source | 263,725,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 313,597,000Source | 240,062,000Source | 286,823,000Source | 303,622,000Source | 297,775,000Source | 242,799,000Source | 1,178,498,000Source | 981,048,000Source | 643,410,000Source | 432,117,000Source |
| Operating Income (Loss)USD | — | — | 137,363,000Source | 48,098,000Source | 182,432,000Source | 76,109,000Source | 150,388,000Source | 97,004,000Source | 479,816,000Source | 165,991,000Source | 133,142,000Source | 227,951,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 1,537,000Source | -570,000Source | 1,171,000Source | 772,000Source | 2,247,000Source | 713,000Source | 3,413,000Source | 2,205,000Source | 32,251,000Source | 15,068,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 143,994,000Source | 57,032,000Source | 189,817,000Source | 188,173,000Source | 157,074,000Source | 103,668,000Source | 605,068,000Source | 120,722,000Source | 165,393,000Source | 243,019,000Source |
| Income Tax Expense (Benefit)USD | — | — | 25,028,000Source | 5,196,000Source | 38,248,000Source | -14,673,000Source | 32,772,000Source | 28,206,000Source | 67,200,000Source | 17,738,000Source | 42,520,000Source | 52,850,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 118,966,000Source | 51,836,000Source | 151,569,000Source | 202,846,000Source | 124,302,000Source | 75,462,000Source | 537,868,000Source | 102,984,000Source | 122,873,000Source | 190,169,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.88Source | 0.38Source | 1.12Source | 1.5Source | 0.92Source | 0.55Source | 3.98Source | 0.76Source | 1.09Source | 1.89Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.88Source | 0.38Source | 1.1Source | 1.49Source | 0.9Source | 0.54Source | 3.92Source | 0.75Source | 1.07Source | 1.85Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 134,502,000Source | 135,615,000Source | 135,054,000Source | 135,205,000Source | 135,364,000Source | 136,757,000Source | 135,215,000Source | 135,726,000Source | 113,087,000Source | 100,469,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 135,394,000Source | 138,062,000Source | 137,384,000Source | 136,499,000Source | 138,191,000Source | 139,774,000Source | 137,056,000Source | 137,863,000Source | 114,630,000Source | 102,643,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 29,843,000Source | 30,076,000Source | 29,560,000Source | 30,189,000Source | 29,526,000Source | 28,802,000Source | 118,194,000Source | 119,373,000Source | 51,032,000Source | 17,735,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | -2,713,000Source | -3,617,000Source | 11,080,000Source | 33,156,000Source | 6,377,000Source | 1,057,000Source | 42,326,000Source | 29,623,000Source | 68,274,000Source | 5,959,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | 151,775,000Source | 100,769,000Source | 75,180,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -161,000Source | 10,279,000Source | -860,000Source | 38,000Source | -2,113,000Source | 4,270,000Source | -3,006,000Source | -43,285,000Source | 14,259,000Source | -1,020,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | -3,000,000Source | -43,300,000Source | 14,100,000Source | — |
| Goodwill, Impairment LossUSD | — | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | — | — | — | — | — | — | — | — | 1,020,302,000Source | 759,118,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 586,468,000Source | 149,514,000Source | 181,752,000Source | 247,260,000Source |
| Interest Income (Expense), NetUSD | — | — | 1,455,000Source | -775,000Source | — | 693,000Source | — | 1,681,000Source | — | -4,189,000Source | 20,130,000Source | 14,233,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | — | 7,074,000Source | 693,000Source | 5,434,000Source | 1,681,000Source | 7,141,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 118,966,000Source | 51,836,000Source | 151,569,000Source | 202,846,000Source | 124,301,000Source | 75,462,000Source | 537,868,000Source | 102,984,000Source | 122,873,000Source | — |
| Nonoperating Income (Expense)USD | — | — | 6,631,000Source | 8,934,000Source | 7,385,000Source | 112,064,000Source | 6,686,000Source | 6,664,000Source | 125,252,000Source | -45,269,000Source | — | — |
| Operating ExpensesUSD | — | — | — | — | — | — | — | — | — | — | 887,160,000Source | 531,167,000Source |
| Research and Development ExpenseUSD | — | — | 38,067,000Source | 35,380,000Source | 36,321,000Source | 39,954,000Source | 36,510,000Source | 33,062,000Source | 147,246,000Source | 163,754,000Source | 124,010,000Source | 73,015,000Source |
| Restructuring CostsUSD | — | — | 358,000Source | 5,191,000Source | 1,957,000Source | 13,547,000Source | 5,212,000Source | 0Source | 15,049,000Source | 23,773,000Source | — | — |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | — | 11,508,000Source | 12,303,000Source | 13,423,000Source | 40,583,000Source | 12,788,000Source | 13,324,000Source | 76,530,000Source | 54,286,000Source | 52,773,000Source | 33,467,000Source |
Filing attachments
gmed-q22026ex991.htm · 8-K · 2026-08-06
EX-99.1 2 gmed-q22026ex991.htm EX-99.1 Document Exhibit 99.1 Globus Medical Reports Second Quarter 2026 Results AUDUBON, PA., August 6, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026. Second Quarter 2026: • Worldwide net sales were $789.6 million, an increase of 5.9%, or an increase of 5.6% on a constant currency basis. • GAAP net income for the quarter was $151.6 mi…
Read attachment ↗gmed-q12026ex991.htm · 8-K · 2026-05-07
EX-99.1 2 gmed-q12026ex991.htm EX-99.1 Document Exhibit 99.1 Globus Medical Reports First Quarter 2026 Results AUDUBON, PA., May 7, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026: • Worldwide net sales were $759.9 million, an increase of 27.0%, or an increase of 25.5% on a constant currency basis. • Base business, excluding Nevro, net sales were $…
Read attachment ↗gmed-323268kex991.htm · 8-K · 2026-03-23
EX-99.1 2 gmed-323268kex991.htm EX-99.1 Document Exhibit 99.1 Globus Medical Announces Board Departure AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) - Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, Ph. D., a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026…
Read attachment ↗gmed-ye2025ex991.htm · 8-K · 2026-02-24
EX-99.1 2 gmed-ye2025ex991.htm EX-99.1 Document Exhibit 99.1 Globus Medical Reports Fourth Quarter and Full Year 2025 Results AUDUBON, PA, February 24, 2026: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: • Worldwide net sales were $826.4 million, an increase of 25.7%, or an increase of 24.7% on a constant currency basis. • Base…
Read attachment ↗gmed-20251106xex99_1.htm · 8-K · 2025-11-06
EX-99.1 2 gmed-20251106xex99_1.htm EX-99.1 Exhibit 991 Earnings Release Exhibit 99.1 Globus Medical Reports Third Quarter 2025 Results AUDUBON, PA, November 6, 2025: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025. Worldwide net sales were $769.0 million, an increase of 22.9%, or an increase of 22.3% on a constant currency basis Base business, excluding Nevro, n…
Read attachment ↗gmed-20250807xex99_1.htm · 8-K · 2025-08-07
EX-99.1 2 gmed-20250807xex99_1.htm EX-99.1 Exhibit 991 Earnings Release Exhibit 99.1 Globus Medical Reports Second Quarter 2025 Results AUDUBON, PA, August 7, 2025: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025. Worldwide net sales were $745.3 million, an increase of 18.4%, or an increase of 17.6% on a constant currency basis GAAP net income for the quarter was $20…
Read attachment ↗